Davis JM - Search Results

1

Dose Equivalents for Antipsychotic Drugs: The DDD Method.

Leucht S, Samara M, Heres S, Davis JM. Leucht S, et al. Among authors: davis jm. Schizophr Bull. 2016 Jul;42 Suppl 1(Suppl 1):S90-4. doi: 10.1093/schbul/sbv167. Schizophr Bull. 2016. PMID: 27460622 Free PMC article.

2

Cerebrospinal fluid somatostatin concentrations in schizophrenia and schizoaffective disorder: the effects of antipsychotic treatment.

Sharma RP, Bissette G, Janicak P, Davis JM, Nemeroff CB. Sharma RP, et al. Among authors: davis jm. Schizophr Res. 1994 Sep;13(2):173-7. doi: 10.1016/0920-9964(94)90099-x. Schizophr Res. 1994. PMID: 7986775

3

Antipsychotic dosing strategies in acute schizophrenia.

Janicak PG, Davis JM. Janicak PG, et al. Among authors: davis jm. Int Clin Psychopharmacol. 1996 May;11 Suppl 2:35-40. doi: 10.1097/00004850-199605002-00006. Int Clin Psychopharmacol. 1996. PMID: 8803658 Review.

4

Clinical profile of an atypical antipsychotic: risperidone.

Davis JM, Chen N. Davis JM, et al. Schizophr Bull. 2002;28(1):43-61. doi: 10.1093/oxfordjournals.schbul.a006925. Schizophr Bull. 2002. PMID: 12047021

5

Dose response and dose equivalence of antipsychotics.

Davis JM, Chen N. Davis JM, et al. J Clin Psychopharmacol. 2004 Apr;24(2):192-208. doi: 10.1097/01.jcp.0000117422.05703.ae. J Clin Psychopharmacol. 2004. PMID: 15206667 Review.

6

Intramuscular haloperidol and olanzapine begin to reduce psychosis within 24 hours.

Leucht S, Davis JM. Leucht S, et al. Among authors: davis jm. Evid Based Ment Health. 2006 Feb;9(1):9. doi: 10.1136/ebmh.9.1.9. Evid Based Ment Health. 2006. PMID: 16436549 No abstract available.

7

Is the superior efficacy of new generation antipsychotics an artifact of LOCF?

Leucht S, Engel RR, Bäuml J, Davis JM. Leucht S, et al. Among authors: davis jm. Schizophr Bull. 2007 Jan;33(1):183-91. doi: 10.1093/schbul/sbl025. Epub 2006 Aug 11. Schizophr Bull. 2007. PMID: 16905632 Free PMC article.

8

Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs.

Leucht S, Davis JM, Engel RR, Kane JM, Wagenpfeil S. Leucht S, et al. Among authors: davis jm. Neuropsychopharmacology. 2007 Sep;32(9):1903-10. doi: 10.1038/sj.npp.1301325. Epub 2007 Feb 7. Neuropsychopharmacology. 2007. PMID: 17287825

9

Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research.

McMahon RP, Kelly DL, Boggs DL, Li L, Hu Q, Davis JM, Carpenter WT Jr. McMahon RP, et al. Among authors: davis jm. Schizophr Bull. 2008 Mar;34(2):292-301. doi: 10.1093/schbul/sbm152. Epub 2008 Jan 8. Schizophr Bull. 2008. PMID: 18184634 Free PMC article.

10

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature.

Stone JM, Davis JM, Leucht S, Pilowsky LS. Stone JM, et al. Among authors: davis jm. Schizophr Bull. 2009 Jul;35(4):789-97. doi: 10.1093/schbul/sbn009. Epub 2008 Feb 26. Schizophr Bull. 2009. PMID: 18303092 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,108 results

Search Page